SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oncopeptides Completes Directed Issue of 50 Million Shares

Oncopeptides completed a directed issue of 50,000,000 ordinary shares. Total shares outstanding are now 445,287,003, including 431,357,758 ordinary shares and 13,929,245 class C shares.

ONCO

Related stories